NM_001172509.2(SATB2):c.1166G>A (p.Arg389His) AND Inborn genetic diseases

This record was updated by the submitter. Please see the current version.

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jun 30, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003099134.1

Allele description

NM_001172509.2(SATB2):c.1166G>A (p.Arg389His)

Gene:

SATB2:SATB homeobox 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2q33.1

Genomic location:

Preferred name:

NM_001172509.2(SATB2):c.1166G>A (p.Arg389His)

HGVS:

NC_000002.12:g.199348708C>T
NG_016976.2:g.127559G>A
NM_001172509.2:c.1166G>AMANE SELECT
NM_001172517.1:c.1166G>A
NM_015265.4:c.1166G>A
NP_001165980.1:p.Arg389His
NP_001165988.1:p.Arg389His
NP_056080.1:p.Arg389His
NC_000002.11:g.200213431C>T
NM_001172509.1:c.1166G>A
NM_015265.3:c.1166G>A

Protein change:

R389H

Molecular consequence:

NM_001172509.2:c.1166G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001172517.1:c.1166G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_015265.4:c.1166G>A - missense variant - [Sequence Ontology: SO:0001583]

Observations:

Condition(s)

Name:: Inborn genetic diseases
Identifiers:: MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003561046	Ambry Genetics	criteria provided, single submitter (Ambry General Variant Classification Scheme_2022)	Uncertain significance (Jun 30, 2021)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003561046

Ambry Genetics

criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)

Uncertain significance
(Jun 30, 2021)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	1	not provided	not provided	1	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003561046.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

Description

The c.1166G>A (p.R389H) alteration is located in exon 8 (coding exon 6) of the SATB2 gene. This alteration results from a G to A substitution at nucleotide position 1166, causing the arginine (R) at amino acid position 389 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	1	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Feb 14, 2024

ClinVar

Relating variation to medicine